Location: Home
  • search
  • go
  • Relate News
  • 12/17/2020CDE Issues the Technical Guidelines for Biological Effect Detection St...
  • 12/15/2020State Council Supports Commercial Health Insurance to Supplement the B...
  • 12/15/2020SMEI Forecasts Rise of Startups, Premium Generics, Self-paid Meds and ...
  • 12/15/2020Ping An Good Doctor and Tsumura (China) Enter into Strategic Cooperati...
  • 12/15/2020Shandong Kexing Bio Debuts IPO on Shanghai STAR Market
  • 12/15/2020Oncocyte and Burning Rock Execute Strategic Agreement to Distribute De...
  • 12/14/2020PharmaBlock Enters Strategic Partnership with Ascentage Pharma
  • 12/14/2020Global Investors Worried as China's Major Companies Default
  • 12/13/2020PharmaDJ: First Chinese Regulation for Customized Commercial Insurance...
  • 12/11/2020State Council Approves Draft Regulation on the Use of Medical Insuranc...
  • 12/10/2020NMPA Reinstates Import of LLM's Difrarel Tablets
  • 12/9/2020NHSA Sets Up Expert Bank for Regional Point-based Global Budgetary Man...
  • 12/9/2020Chi-Med Commences Construction of a Large-Scale Manufacturing Plant i...
  • 12/9/2020Immutep and EOC to Start Phase II Metastatic Breast Cancer Study
  • 12/8/2020Henlius Adalimumab Biosimilar Approved by NMPA
  • 12/8/2020JD Health Jumps 56% in Hong Kong Debut
  • 12/8/2020UCB Gains Chinese Approval for New Indication of KEPPRA (Levetiracetam...
  • 12/8/2020Ascentage Announces Positive Data from Pivotal Phase II Studies of HQP...
  • 12/7/2020Amgen Launches Prolia (Denosumab Injection) in China
  • 12/7/2020Sinovac Gets $515M Investment from Sino Biopharma to Double Covid-19 V...
  • 12/7/2020Takeda Granted Chinese Approval of HAE Drug TAKHZYRO (Lanadelumab)
  • 12/7/2020BeiGene Announces Chinese Approval of BLINCYTO (Blinatumomab) 
  • 12/7/2020Nabriva and Sinovant Restructure License Deal for XENLETA for CABP i...
  • 12/4/2020Recent Executive Moves
  • 12/3/2020NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance Q...
  • 12/3/2020Ascentage Pharma to Start Leukaemia Therapy Trial in US and China
  • 12/2/2020JW to Conduct Clinical Trials of Gout Treatment in China
  • 12/2/2020MSD Secures Chinese Approval of HIV Drug Pifeltro (Doravirine)
  • 12/2/2020Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
  • 12/2/2020Etherna and China Grand Pharma Set Up Joint Venture to Tap into mRNA V...
  • Page:101/357 Total number of articles:10684: [First][<<] [99] [100] [101] [102] [103] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group